Alopecia

Related records

Broader conditions (7)

• Disease
• Disease by body system or component
• Disorder of pilosebaceous unit
• Hair anomaly
• Human disease
• Integumentary system disorder
• Skin appendage disorder

Narrower conditions (50)

• Alopecia antibody deficiency
• Alopecia areata
• Alopecia areata 1
• Alopecia areata 2
• Alopecia mucinosa
• Alopecia totalis
• Alopecia universalis
• Alopecia universalis congenita
• Alopecia universalis onychodystrophy vitiligo
• Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome
• Alopecia, androgenetic, 1
• Alopecia, androgenetic, 2
• Alopecia, androgenetic, 3
• Alopecia, congenital
• Alopecia, isolated
• Androgenetic alopecia
• Atrichia with papular lesions
• Baldness, male pattern
• Central centrifugal cicatricial alopecia
• Chemotherapy-induced alopecia

Trials (461)

• "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
• "iRestore" Light Therapy Apparatus
• 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
• 1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss
• 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
• 6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
• A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)
• A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
• A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of Alopecia
• A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
• A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).
• A Clinical Study to Assess the Safety and Effectiveness of Plant Based Biotin in Healthy Human Subjects With Thin, Dry, and Brittle Hair
• A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin with Silica in Healthy Human Subjects with Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin
• A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
• A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
• A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
• A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
• A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
• A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
• A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

Approved drugs (2)

• Finasteride
• Minoxidil

Drugs in development (15)

• Alcohol Phase 2
• Ammonium trichlorotellurate Phase 2
• Bimatoprost Phase 2
• Deuruxolitinib Phase 2
• Dimethylcurcumin Phase 2
• Diphencyprone Phase 2
• Dutasteride Phase 3
• Ifidancitinib Phase 2
• Palifermin Early phase 1
• Secukinumab Phase 2
• Setipiprant Phase 2
• Sodium chloride Phase 3
• Tacrolimus anhydrous Phase 1
• Tempol Phase 2
• ZINC ION Phase 1

Other linked drugs (3)

• Dalosirvat
• Ritlecitinib
• Roxithromycin